19 June 2013
Keywords: osi, phgarma, pfizer, announce, phase, iv, macugen
Article | 03 July 2006
USA-based OSI Pharmaceuticals and world drugs giant Pfizer have announced the initiation of a Phase IV trial of Macugen (pegaptanib),
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 July 2006
© 2013 thepharmaletter.com